Evidence map›Paper›PMID 30911085›Full record

ArticleScientific reports2019

Phenylpyrrole fungicides act on triosephosphate isomerase to induce methylglyoxal stress and alter hybrid histidine kinase activity.

T Tristan Brandhorst, Iain R L Kean, Stephanie M Lawry, Darin L Wiesner, Bruce S Klein

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 66 citations in OpenAlex.

  1. Conformational diversity in poly-HAMP arrays and its implications for signal transduction.Protein science : a publication of the Protein Society · 2026
    Article
  2. Review
  3. Review
  4. Proteomic Changes inJournal of proteome research · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Polypeptides TargetingJournal of fungi (Basel, Switzerland) · 2023
    Article
  10. Review
  11. Induced Expression ofMicroorganisms · 2023
    Article
  12. Article
  13. Detection ofMicroorganisms · 2022
    Article
  14. Article
  15. Exploring Potential Mechanisms of Fludioxonil Resistance inJournal of fungi (Basel, Switzerland) · 2022
    Article
  16. Journal of fungi (Basel, Switzerland) · 2022
    Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

T Tristan BrandhorstDepartments of Pediatrics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, 53792, USA.
Iain R L KeanDepartments of Pediatrics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, 53792, USA.
Stephanie M LawryDepartments of Pediatrics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, 53792, USA.
Darin L WiesnerDepartments of Pediatrics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, 53792, USA.
Bruce S KleinDepartments of Pediatrics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, 53792, USA. bsklein@wisc.edu.
University of Wisconsin–Madison · US

Funding

Novel antimicrobials targeting MDR pathogens from animal microbial symbiontsU19AI142720 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI ANDES, DAVID R · 2019 to 2023
$30.1M
Metabolomics driven discovery of drug leads from symbiotic bacteriaU19AI109673 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI CLARDY, JON, CURRIE, CAMERON ROBERT · 2014 to 2018
$16.2M
PROTECTIVE IMMUNE RESPONSES TO BLASTOMYCES DERMATITIDISR01AI040996 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI KLEIN, BRUCE STEVEN, WUETHRICH, MARCEL · 1997 to 2023
$10.4M
Wisconsin Allergy Research Training (WISCART) ProgramT32AI007635 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI James E. Gern, DANIEL J JACKSON · 2000 to 2026
$6.5M
MOLECULAR PATHOGENESIS OF BLASTOMYCOSISR01AI035681 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI KLEIN, BRUCE STEVEN · 1995 to 2019
$3.9M
Hybrid histidine kinase: a drug target and path to anti-fungal drug developmentR21AI123758 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI KLEIN, BRUCE STEVEN · 2017 to 2018
$408k
NIAID NIH HHS R01 AI035681NIAID NIH HHS R01 AI040996NIAID NIH HHS R21 AI123758NIAID NIH HHS T32 AI007635NIAID NIH HHS U19 AI109673NIAID NIH HHS U19 AI142720
6 · The paper itself

Abstract

Fludioxonil, a natural product of pyrrolnitrin, is a potent fungicide used on crops worldwide. Drug action requires the presence of a group III hybrid histidine kinase (HHK) and the high osmolarity glycerol (HOG) pathway. We have reported that the drug does not act directly on HHK, but triggers the conversion of the kinase to a phosphatase, which dephosphorylates Ypd1 to constitutively activate HOG signaling. Still, the direct drug target remains unknown and mode of action ill defined. Here, we heterologously expressed a group III HHK, dimorphism-regulating kinase 1 (Drk1) in Saccharomyces cerevisae to delineate fludioxonil's target and action. We show that the drug interferes with triosephosphate isomerase (TPI) causing release of methylglyoxal (MG). MG activates the group III HHK and thus the HOG pathway. Drug action involved Drk1 cysteine 392, as a C392S substitution increased drug resistance in vivo. Drug sensitivity was reversed by dimedone treatment, indicating Drk1 responds in vivo to an aldehydic stress. Fludioxonil treatment triggered elevated cytosolic methylglyoxal. Likewise, methylglyoxal treatment of Drk1-expressing yeast phenocopied treatment with fludioxonil. Fludioxonil directly inhibited TPI and also caused it to release methylglyoxal in vitro. Thus, TPI is a drug target of the phenylpyrrole class of fungicides, inducing elevated MG which alters HHK activity, likely converting the kinase to a phosphatase that acts on Ypd1 to trigger HOG pathway activation and fungal cell death.

Indexed as

Histidine KinaseSaccharomyces cerevisiae ProteinsStress, PhysiologicalAmino Acid SubstitutionDioxolesDrug Resistance, FungalMutation, MissensePyrrolesPyruvaldehydeSaccharomyces cerevisiaeTriose-Phosphate IsomeraseDioxolesfludioxonilHistidine KinasePyrrolesPyruvaldehydeSaccharomyces cerevisiae ProteinsTriose-Phosphate Isomerase

Identifiers

PMID30911085
PMCPMC6433957
OpenAlexW2924401234

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.